Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

232.75
-1.8100-0.77%
Post-market: 233.050.3000+0.13%17:39 EDT
Volume:796.45K
Turnover:185.00M
Market Cap:30.13B
PE:-106.81
High:237.77
Open:230.36
Low:228.28
Close:234.56
Loading ...

Alnylam Pharmaceuticals Is Maintained at Buy by Stifel

Dow Jones
·
31 Mar

Scotiabank Remains a Buy on Alnylam Pharma (ALNY)

TIPRANKS
·
31 Mar

Alnylam Pharma (ALNY) Receives a Buy from Piper Sandler

TIPRANKS
·
31 Mar

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TIPRANKS
·
31 Mar

Alnylam Pharmaceuticals Inc : Stifel Raises Target Price to $345 From $300

THOMSON REUTERS
·
31 Mar

Alnylam Pharmaceuticals Inc : Scotiabank Raises Target Price to $342 From $338

THOMSON REUTERS
·
31 Mar

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip

Simply Wall St.
·
30 Mar

BUZZ-U.S. STOCKS ON THE MOVE-SurgePays, B. Riley, CarMax

Reuters
·
27 Mar

BUZZ-Pfizer's heart disease drug remains 'mainstay treatment' despite new entries, Oppenheimer says

Reuters
·
26 Mar

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)

TIPRANKS
·
26 Mar

Alnylam (ALNY) Surges 11.8%: Is This an Indication of Further Gains?

Zacks
·
24 Mar

Alnylam Pharmaceuticals Raised to Overweight From Neutral by JP Morgan

Dow Jones
·
24 Mar

JPMorgan Upgrades Alnylam Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $328 From $280

MT Newswires Live
·
24 Mar

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Sees 17% Weekly Gain As Vutrisiran Faces FDA Decision

Simply Wall St.
·
24 Mar

Alnylam price target raised to $338 from $300 at Scotiabank

TipRanks
·
22 Mar

Alnylam Pharma Stock (ALNY) Rockets on FDA Drug Approval

TIPRANKS
·
22 Mar

Alnylam Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
22 Mar

Alnylam Stock Jumps After the FDA Approves Its Heart Drug -- WSJ

Dow Jones
·
22 Mar

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

Zacks
·
22 Mar